Eran Elinav

Eran Elinav at the Weizmann Institute is a globally recognized microbiome scientist who has developed personalized approaches to microbiome-based interventions in cancer. His research has identified specific bacterial signatures that predict immunotherapy response across tumor types and investigated how microbiome metabolites modulate immune function. He co-leads large-scale microbiome-IO prospective cohort studies.